[Edaily Reporter KIM YOON-JEONG ] SAMSUNG C&T CORPORATION is trading higher in early trading. This is believed to be driven by heightened expectations of a revaluation stemming from the rising value of its stakes in major affiliates such as SamsungElectronics and Samsung Life Insurance.

According to MP Doctor on the 23rd, as of 9:18 a.m. today, SAMSUNG C&T CORPORATION(028260)is trading at 538,000 won, up 18,000 won (3.46%) from the previous trading day.
On the same day, reports were released by securities firms raising their target prices for SAMSUNG C&T CORPORATION. HEUNGKUK METALTECH CO.,LTD. raised its target price for SAMSUNG C&T CORPORATION from 580,000 won to 700,000 won and maintained its “Buy” investment rating.
Park Jong-ryul, an analyst at Heungkuk Securities, stated, “Since last April, the value of Samsung C&T’s stakes in affiliates such as SamsungElectronics and Samsung Life Insurance has risen rapidly, accelerating the revaluation of SAMSUNG C&T CORPORATION’s stock price.” He added, “This revaluation is expected to continue, driven by robust earnings momentum and expanded shareholder returns.”
SAMSUNG C&T CORPORATION holds a 5.05% stake in SamsungElectronics, a 19.34% stake in Samsung Life Insurance, and a 43.1% stake in SAMSUNG BIOLOGICS, among others. Heungkuk Securities estimated the value of its stakes in major affiliates to be approximately 159 trillion won.
Analyst Park explained, “We have raised our target price in light of the rising value of stakes in affiliated companies,” adding, “The 12-month forward price-to-book ratio (PBR) stands at 1.2x, and the stock remains undervalued with a discount of 55.5% relative to net asset value (NAV).”
He further cited performance driven by the biotech sector, the expansion of new businesses such as nuclear power, renewable energy, and data centers, and shareholder return policies as factors contributing to the rise in corporate value.